Literature DB >> 11171792

Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later.

J Sundström1, L Lind, B Vessby, B Andrén, A Aro, H Lithell.   

Abstract

BACKGROUND: -Left ventricular hypertrophy (LVH) is a common risk factor for cardiovascular mortality. Causes other than hypertension have not previously been investigated longitudinally. The aim of the present study was to determine hemodynamic, metabolic, and psychosocial predictors at 50 years of age for the prevalence of echocardiographic LVH and geometric subtypes at age 70 by use of a large sample of men from the general population followed up for 20 years. Methods and Results-In 1970 to 1973, all men born from 1920 to 1924 and residing in Uppsala County, Sweden, were invited to participate in a health survey aimed at identifying risk factors for cardiovascular disease. At a reinvestigation 20 years later, echocardiographic left ventricular mass index was determined in 475 subjects. A 1-SD increase in body mass index, systolic or diastolic blood pressure, fasting LDL/HDL cholesterol, serum triglycerides, or the serum cholesterol ester proportion of several saturated fatty acids or oleic acid at age 50 significantly increased the odds of having LVH at age 70 by 27% to 41%, whereas an increase in linoleic acid proportion was protective. Almost all metabolic predictors were independent of ischemic heart disease, valvular disease, and use of antihypertensive medication at age 70.
CONCLUSIONS: -Dyslipidemia and indices of a low dietary intake of linoleic acid and high intake of saturated and monounsaturated fats, as well as hypertension and obesity, at age 50 predicted the prevalence of LVH 20 years later in this prospective longitudinal cohort study, thereby suggesting that lipids may be important in the origin of LVH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171792     DOI: 10.1161/01.cir.103.6.836

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Cross-sectional associations of food consumption with plasma fatty acid composition and estimated desaturase activities in Finnish children.

Authors:  Taisa Venäläinen; Ursula Schwab; Jyrki Ågren; Vanessa de Mello; Virpi Lindi; Aino-Maija Eloranta; Sanna Kiiskinen; David Laaksonen; Timo A Lakka
Journal:  Lipids       Date:  2014-05       Impact factor: 1.880

2.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

3.  Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men.

Authors:  E Warensjö; U Risérus; B Vessby
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

4.  Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels.

Authors:  Yan-wen Qin; Ping Ye; Ji-qiang He; Li Sheng; Lu-ya Wang; Jie Du
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

5.  Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis.

Authors:  Susan R Heckbert; Wendy Post; Gregory D N Pearson; Donna K Arnett; Antoinette S Gomes; Michael Jerosch-Herold; W Gregory Hundley; Joao A Lima; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

6.  Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

Authors:  Rima Kaddurah-Daouk; Rebecca A Baillie; Hongjie Zhu; Zhao-Bang Zeng; Michelle M Wiest; Uyen Thao Nguyen; Steven M Watkins; Ronald M Krauss
Journal:  Metabolomics       Date:  2010-04-01       Impact factor: 4.290

7.  Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.

Authors:  Sumita Mishra; Djahida Bedja; Christine Amuzie; Alberto Avolio; Subroto Chatterjee
Journal:  Biochem Biophys Res Commun       Date:  2015-08-04       Impact factor: 3.575

8.  Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.

Authors:  Hilary P Glazer; Robert M Osipov; Richard T Clements; Frank W Sellke; Cesario Bianchi
Journal:  Cell Cycle       Date:  2009-06-03       Impact factor: 4.534

9.  A high activity index of stearoyl-CoA desaturase is associated with increased risk of fracture in men.

Authors:  H Melhus; U Risérus; E Warensjö; L Wernroth; K Jensevik; L Berglund; B Vessby; K Michaëlsson
Journal:  Osteoporos Int       Date:  2007-12-08       Impact factor: 4.507

10.  Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulin.

Authors:  Jeong-A Kim; Hyun-Ju Jang; Daniel H Hwang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-08       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.